Key Biden administration decisions on how to implement the US Medicare program’s new drug price negotiation authorities could help the government in its attempts to quash the pharmaceutical industry’s and other challenges to the Inflation Reduction Act program in court, legal experts say.
Stealth Defense: Medicare, IRS Implementation May Weaken Pharma’s Arguments Against IRA
Flexibility included in guidance issued after many IRA lawsuits were filed put some of the arguments industry has made on shakier footing, legal experts explain.
